Literature DB >> 1778665

Epidermal growth factor in human tear fluid: a minireview.

G B van Setten1, T Tervo, L Viinikka, J Perheentupa, A Tarkkanen.   

Abstract

This minireview deals with the presence of epidermal growth factor (EGF) in human tear fluid. It explains the occurrence of EGF in tear fluid, the origin of EGF and its dependency on tear fluid dynamics. The alterations in tear fluid EGF concentrations that occur during diseases of the ocular surface are described and discussed in the context of the current knowledge about the interaction between EGF and EGF receptors. The possible clinical implications of topical treatment with EGF are considered.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1778665     DOI: 10.1007/bf00137945

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  30 in total

1.  Isolation and structure of urogastrone and its relationship to epidermal growth factor.

Authors:  H Gregory
Journal:  Nature       Date:  1975-09-25       Impact factor: 49.962

2.  Stimulation of corneal endothelial cell proliferations in vitro by fibroblast and epidermal growth factors.

Authors:  D Gospodarowicz; A L Mescher; C R Birdwell
Journal:  Exp Eye Res       Date:  1977-07       Impact factor: 3.467

3.  Epidermal growth factor in human tear fluid: increased release but decreased concentrations during reflex tearing.

Authors:  G B van Setten
Journal:  Curr Eye Res       Date:  1990-01       Impact factor: 2.424

4.  Presence of epidermal growth factor in human tears.

Authors:  Y Ohashi; M Motokura; Y Kinoshita; T Mano; H Watanabe; S Kinoshita; R Manabe; K Oshiden; C Yanaihara
Journal:  Invest Ophthalmol Vis Sci       Date:  1989-08       Impact factor: 4.799

Review 5.  Growth factors and their action in vivo and in vitro.

Authors:  D Gospodarowicz
Journal:  J Pathol       Date:  1983-11       Impact factor: 7.996

6.  Epidermal growth factor: identification of a new hormone in human urine.

Authors:  R H Starkey; S Cohen; D N Orth
Journal:  Science       Date:  1975-09-05       Impact factor: 47.728

7.  Biosynthetic human EGF accelerates healing of Neodecadron-treated primate corneas.

Authors:  J R Brightwell; S L Riddle; R A Eiferman; P Valenzuela; P J Barr; J P Merryweather; G S Schultz
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-01       Impact factor: 4.799

8.  Size heterogeneity of epidermal growth factor in human body fluids.

Authors:  K Pesonen; L Viinikka; A Koskimies; A R Banks; M Nicolson; J Perheentupa
Journal:  Life Sci       Date:  1987-06-29       Impact factor: 5.037

9.  Rabbit corneal endothelial cells in vitro: effects of EGF.

Authors:  G M Raymond; M M Jumblatt; S P Bartels; A H Neufeld
Journal:  Invest Ophthalmol Vis Sci       Date:  1986-04       Impact factor: 4.799

10.  Epidermal growth factor-like, corneal wound healing substance in mouse tears.

Authors:  O Tsutsumi; A Tsutsumi; T Oka
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

View more
  4 in total

Review 1.  Novel strategies for anterior segment ocular drug delivery.

Authors:  Kishore Cholkar; Sulabh P Patel; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  J Ocul Pharmacol Ther       Date:  2012-12-05       Impact factor: 2.671

2.  Osmoprotective effects of supplemental epidermal growth factor in an ex vivo multilayered human conjunctival model under hyperosmotic stress.

Authors:  Jae-hyung Kim; Soon-Suk Kang; Eun Soon Kim; Jae Yong Kim; Myoung Joon Kim; Hungwon Tchah
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-05-16       Impact factor: 3.117

3.  Transforming growth factor-alpha is a constant component of human tear fluid.

Authors:  G van Setten; G Schultz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-09       Impact factor: 3.117

Review 4.  Variable Responses to Corneal Grafts: Insights from Immunology and Systems Biology.

Authors:  Antonio Di Zazzo; Sang-Mok Lee; Jaemyoung Sung; Matteo Niutta; Marco Coassin; Alireza Mashaghi; Takenori Inomata
Journal:  J Clin Med       Date:  2020-02-21       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.